Cure arthritis with 'nano fat'

Arthritis is one of the most common diseases in middle-aged and older people, symptoms are persistent pain in the joints and depending on the severity can lead to disability, even death. Some current treatment drugs are largely unable to address the disease, whereas they often cause serious side effects, such as internal bleeding.

Photo: abcnews

However, this concern can be addressed with the new 'nano-fat' treatment called Flexiseq . This is the first non-prescription drug that applies nanotechnology with components of nanoscale spherical molecules made of natural phospholipid fat that features lubrication of joints. When applying the treatment, the patient only needs to lightly apply a layer of gel on the skin, which is a phospholipid molecule that can easily follow pores permeable to the joint and begin the task of lubricating instead of the lost natural oil. .

According to the test results on 4,000 people of Professor Philip Conaghan of the Institute of Rheumatology and Musculoskeletal Medicine of the University of Leeds (UK), Flexiseq has the effect of reducing pain and improving motion effectively like nonsteroidal anti-inflammatory drugs are aspirin and Celebrex. The only side effect of Flexiseq is that it can cause the skin to apply gel in some mild inflammatory patients.

With the above success, the medical community believes that Flexiseq's mechanism of action not only helps to treat joint pain effectively or modulate drugs to treat inflammation or skin infections, but also opens a new way to put drugs into the body need injection in the treatment of other diseases, such as diabetes or cancer.